Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Jul;96(1):394–400. doi: 10.1172/JCI118047

Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols.

J E Freedman 1, B Frei 1, G N Welch 1, J Loscalzo 1
PMCID: PMC185212  PMID: 7615810

Abstract

GSH peroxidase (Px) catalyzes the reduction of lipid hydroperoxides (LOOH), known metabolic products of platelets and vascular cells. Because interactions between these cells are modulated by nitric oxide (NO) and LOOH inactivate NO, we investigated the effect of GSH-Px on the inhibition of platelet function by the naturally occurring S-nitrosothiol, S-nitroso-glutathione (SNO-Glu). Concentrations of SNO-Glu that alone did not inhibit platelet function (subthreshold inhibitory concentrations) were added to platelet-rich plasma together with GSH-Px (0.2-20 U/ml); this led to a dose-dependent inhibition of platelet aggregation with an IC50 of 0.6 U/ml GSH-Px. In the presence of subthreshold inhibitory concentrations of SNO-Glu, the LOOH, 5-hydroperoxy-6,8,11,14-eicosatetraenoic acid, increased platelet aggregation, an effect reversed by GSH-Px. Glutathione and SNO-Glu were equally effective as cosubstrates for GSH-Px. Incubation of SNO-Glu with GSH-Px for 1 min led to a 48.5% decrease in the concentration of SNO-Glu. Incubation of SNO-Glu with serum albumin led to the formation of S-nitroso-albumin, an effect enhanced by GSH-Px. These observations suggest that GSH-Px has two functions: reduction of LOOH, thereby preventing inactivation of NO, and metabolism of SNO-Glu, thereby liberating NO and/or supporting further transnitrosation reactions.

Full text

PDF
394

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aharony D., Smith J. B., Silver M. J. Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid. Biochim Biophys Acta. 1982 Oct 8;718(2):193–200. doi: 10.1016/0304-4165(82)90219-7. [DOI] [PubMed] [Google Scholar]
  2. Avissar N., Whitin J. C., Allen P. Z., Palmer I. S., Cohen H. J. Antihuman plasma glutathione peroxidase antibodies: immunologic investigations to determine plasma glutathione peroxidase protein and selenium content in plasma. Blood. 1989 Jan;73(1):318–323. [PubMed] [Google Scholar]
  3. Azuma H., Ishikawa M., Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol. 1986 Jun;88(2):411–415. doi: 10.1111/j.1476-5381.1986.tb10218.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BORN G. V., CROSS M. J. THE AGGREGATION OF BLOOD PLATELETS. J Physiol. 1963 Aug;168:178–195. doi: 10.1113/jphysiol.1963.sp007185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bryant R. W., Simon T. C., Bailey J. M. Hydroperoxy fatty acid formation in selenium deficient rat platelets: coupling of glutathione peroxidase to the lipoxygenase pathway. Biochem Biophys Res Commun. 1983 Nov 30;117(1):183–189. doi: 10.1016/0006-291x(83)91558-9. [DOI] [PubMed] [Google Scholar]
  6. Buczyński A., Wachowicz B., Kedziora-Kornatowska K., Tkaczewski W., Kedziora J. Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. Atherosclerosis. 1993 May;100(2):223–228. doi: 10.1016/0021-9150(93)90208-c. [DOI] [PubMed] [Google Scholar]
  7. Buhl R., Jaffe H. A., Holroyd K. J., Wells F. B., Mastrangeli A., Saltini C., Cantin A. M., Crystal R. G. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet. 1989 Dec 2;2(8675):1294–1298. doi: 10.1016/s0140-6736(89)91909-0. [DOI] [PubMed] [Google Scholar]
  8. Chaudiere J., Wilhelmsen E. C., Tappel A. L. Mechanism of selenium-glutathione peroxidase and its inhibition by mercaptocarboxylic acids and other mercaptans. J Biol Chem. 1984 Jan 25;259(2):1043–1050. [PubMed] [Google Scholar]
  9. Frei B., Stocker R., Ames B. N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9748–9752. doi: 10.1073/pnas.85.24.9748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Frei B., Yamamoto Y., Niclas D., Ames B. N. Evaluation of an isoluminol chemiluminescence assay for the detection of hydroperoxides in human blood plasma. Anal Biochem. 1988 Nov 15;175(1):120–130. doi: 10.1016/0003-2697(88)90369-7. [DOI] [PubMed] [Google Scholar]
  11. Gabrielsen B. O., Opstvedt J. Availability of selenium in fish meal in comparison with soybean meal, corn gluten meal and selenomethionine relative to selenium in sodiumselenite for restoring glutathione peroxidase activity in selenium-depleted chicks. J Nutr. 1980 Jun;110(6):1096–1100. doi: 10.1093/jn/110.6.1096. [DOI] [PubMed] [Google Scholar]
  12. Harland W. A., Gilbert J. D., Brooks C. J. Lipids of human atheroma. 8. Oxidised derivatives of cholesteryl linoleate. Biochim Biophys Acta. 1973 Sep 25;316(3):378–385. [PubMed] [Google Scholar]
  13. Heinecke J. W., Rosen H., Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest. 1984 Nov;74(5):1890–1894. doi: 10.1172/JCI111609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ignarro L. J., Byrns R. E., Buga G. M., Wood K. S. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res. 1987 Dec;61(6):866–879. doi: 10.1161/01.res.61.6.866. [DOI] [PubMed] [Google Scholar]
  15. Jahn B., Hänsch G. M. Oxygen radical generation in human platelets: dependence on 12-lipoxygenase activity and on the glutathione cycle. Int Arch Allergy Appl Immunol. 1990;93(1):73–79. doi: 10.1159/000235282. [DOI] [PubMed] [Google Scholar]
  16. Maddipati K. R., Gasparski C., Marnett L. J. Characterization of the hydroperoxide-reducing activity of human plasma. Arch Biochem Biophys. 1987 Apr;254(1):9–17. doi: 10.1016/0003-9861(87)90075-0. [DOI] [PubMed] [Google Scholar]
  17. Maddipati K. R., Marnett L. J. Characterization of the major hydroperoxide-reducing activity of human plasma. Purification and properties of a selenium-dependent glutathione peroxidase. J Biol Chem. 1987 Dec 25;262(36):17398–17403. [PubMed] [Google Scholar]
  18. Mowri H., Chinen K., Ohkuma S., Takano T. Peroxidized lipids isolated by HPLC from atherosclerotic aorta. Biochem Int. 1986 Feb;12(2):347–352. [PubMed] [Google Scholar]
  19. Pascual P., Martinez-Lara E., Bárcena J. A., López-Barea J., Toribio F. Direct assay of glutathione peroxidase activity using high-performance capillary electrophoresis. J Chromatogr. 1992 Oct 2;581(1):49–56. doi: 10.1016/0378-4347(92)80446-w. [DOI] [PubMed] [Google Scholar]
  20. Radomski M. W., Palmer R. M., Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol. 1987 Sep;92(1):181–187. doi: 10.1111/j.1476-5381.1987.tb11310.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Radomski M. W., Palmer R. M., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987 Nov 7;2(8567):1057–1058. doi: 10.1016/s0140-6736(87)91481-4. [DOI] [PubMed] [Google Scholar]
  22. Radomski M. W., Palmer R. M., Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun. 1987 Nov 13;148(3):1482–1489. doi: 10.1016/s0006-291x(87)80299-1. [DOI] [PubMed] [Google Scholar]
  23. Rubbo H., Radi R., Trujillo M., Telleri R., Kalyanaraman B., Barnes S., Kirk M., Freeman B. A. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem. 1994 Oct 21;269(42):26066–26075. [PubMed] [Google Scholar]
  24. Salonen J. T., Alfthan G., Huttunen J. K., Pikkarainen J., Puska P. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet. 1982 Jul 24;2(8291):175–179. doi: 10.1016/s0140-6736(82)91028-5. [DOI] [PubMed] [Google Scholar]
  25. Scharfstein J. S., Keaney J. F., Jr, Slivka A., Welch G. N., Vita J. A., Stamler J. S., Loscalzo J. In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest. 1994 Oct;94(4):1432–1439. doi: 10.1172/JCI117480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schiavon R., Freeman G. E., Guidi G. C., Perona G., Zatti M., Kakkar V. V. Selenium enhances prostacyclin production by cultured endothelial cells: possible explanation for increased bleeding times in volunteers taking selenium as a dietary supplement. Thromb Res. 1984 Jun 1;34(5):389–396. doi: 10.1016/0049-3848(84)90243-3. [DOI] [PubMed] [Google Scholar]
  27. Shultz P. J., Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest. 1992 Nov;90(5):1718–1725. doi: 10.1172/JCI116045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stamler J. S., Simon D. I., Osborne J. A., Mullins M. E., Jaraki O., Michel T., Singel D. J., Loscalzo J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):444–448. doi: 10.1073/pnas.89.1.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Takahashi K., Avissar N., Whitin J., Cohen H. Purification and characterization of human plasma glutathione peroxidase: a selenoglycoprotein distinct from the known cellular enzyme. Arch Biochem Biophys. 1987 Aug 1;256(2):677–686. doi: 10.1016/0003-9861(87)90624-2. [DOI] [PubMed] [Google Scholar]
  30. Terao J., Shibata S. S., Matsushita S. Selective quantification of arachidonic acid hydroperoxides and their hydroxy derivatives in reverse-phase high performance liquid chromatography. Anal Biochem. 1988 Mar;169(2):415–423. doi: 10.1016/0003-2697(88)90306-5. [DOI] [PubMed] [Google Scholar]
  31. Wendel A., Cikryt P. The level and half-life of glutathione in human plasma. FEBS Lett. 1980 Nov 3;120(2):209–211. doi: 10.1016/0014-5793(80)80299-7. [DOI] [PubMed] [Google Scholar]
  32. Wilkins G. M., Leake D. S. The oxidation of low density lipoprotein by cells or iron is inhibited by zinc. FEBS Lett. 1994 Mar 21;341(2-3):259–262. doi: 10.1016/0014-5793(94)80468-0. [DOI] [PubMed] [Google Scholar]
  33. Wu J., Xu G. L. Plasma selenium content, platelet glutathione peroxidase and superoxide dismutase activity of residents in Kashin-Beck disease affected area in China. J Trace Elem Electrolytes Health Dis. 1987 Sep;1(1):39–43. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES